Tirzepatide staying a dual GLP-1 and GIP agonist, it can be advised the GIP ingredient of dual agonism may be chargeable for the additional advantage, provided the potential benefit of GIP receptor agonism on peripheral insulin sensitization. Therefore, tirzepatide was more practical than dulaglutide in decreasing fasting dietary TAG [6,7].The Ame